Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Jespersen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Reviews. Urology|August 27, 2025
Reply to 'Enhancing spatial transcriptomics in clear-cell renal cell carcinoma'Jesper Jespersen, Iben Lyskjær
Nature Reviews. Urology|January 9, 2025
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinomaJesper Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Radiology|March 3, 2026
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry StudyJohanne Ahrenfeldt, Jesper Jespersen, Pernille Tonnesen, et al.
European Journal of Epidemiology|May 14, 2025
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa studyJohanne Ahrenfeldt, Jesper Jespersen, Jens Ejrnæs Lyngstrand, et al.
Clinical Epigenetics|January 22, 2026
Epigenomic subtypes and prognostic methylation signatures in clear cell renal cell carcinomaLaura Iisager, Cecilie Lindgaard, Johanne Ahrenfeldt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Reviews. Urology|August 27, 2025
Reply to 'Enhancing spatial transcriptomics in clear-cell renal cell carcinoma'Jesper Jespersen, Iben Lyskjær
Nature Reviews. Urology|January 9, 2025
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinomaJesper Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Radiology|March 3, 2026
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry StudyJohanne Ahrenfeldt, Jesper Jespersen, Pernille Tonnesen, et al.
European Journal of Epidemiology|May 14, 2025
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa studyJohanne Ahrenfeldt, Jesper Jespersen, Jens Ejrnæs Lyngstrand, et al.
Clinical Epigenetics|January 22, 2026
Epigenomic subtypes and prognostic methylation signatures in clear cell renal cell carcinomaLaura Iisager, Cecilie Lindgaard, Johanne Ahrenfeldt, et al.
Pageof 1